Bill Manos: Ledger

Stories naming Bill Manos. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Founder	Skin2Neuron	SmartCompany, Synthesis BioVentures

2 deals

The Australian Business Review, S2N term sheet

Sydney biotech Skin2Neuron raised $4 million from SYNthesis BioVentures to develop a hair-follicle cell therapy for Alzheimer's, while the investor reached the first $20 million close of its $75 million bioscience fund.

Synthesis BioVentures Tue 9 Apr 2024 Skin2Neuron SYNthesis BioVentures The University of Sydney Amir Zalcenstein Bill Manos Professor Michael Valenzuela

Also SmartCompany

Bill Manos

Roles

Coverage

Three Aussie startups, and a fast food chain, that raised $247.5 million this week

The Australian Business Review, S2N term sheet